Back to Search Start Over

Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.

Authors :
Van Horssen, Jack
De Vos, Rob A. I.
Steur, Ernst N. H. Jansen
David, Guido
Wesseling, Pieter
De Waal, Robert M. W.
Verbeek, Marcel M.
Source :
Journal of Alzheimer's Disease; 2004, Vol. 6 Issue 5, p469-474, 6p, 1 Color Photograph
Publication Year :
2004

Abstract

alpha-Synuclein is the major constituent of Lewy bodies and Lewy neurites in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Relatively little is known about the exact mechanism of alpha-synuclein deposition and fibrillization in these alpha-synucleinopathies. In order to better understand the pathogenesis of alpha-synucleinopathies it is important to identify molecules that regulate the fibrillization of alpha-synuclein. Since it has been demonstrated that heparan sulfate proteoglycans (HSPGs) and glycosaminoglycans (GAGs) promote the conversion of non-fibrillar amyloid beta-protein (Abeta) into neurotoxic fibrillar Abeta in Alzheimer's disease, they might also be involved in alpha-synuclein aggregation. It was the aim of our study to examine the distribution pattern of these macromolecules in PD brains and the possible association with Lewy bodies and Lewy neurites. Although HSPGs clearly colocalized with senile plaques, we were unable to identify HSPGs or GAGs in Lewy bodies and Lewy neurites and therefore concluded that it is likely that alpha-synuclein fibrillization and stabilization occurs independently of the presence of HSPGs or GAGs. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13872877
Volume :
6
Issue :
5
Database :
Complementary Index
Journal :
Journal of Alzheimer's Disease
Publication Type :
Academic Journal
Accession number :
14797304
Full Text :
https://doi.org/10.3233/JAD-2004-6502